Option Care Health Inc has a consensus price target of $36.5 based on the ratings of 7 analysts. The high is $44 issued by JP Morgan on October 18, 2023. The low is $24 issued by Canaccord Genuity on August 4, 2021. The 3 most-recent analyst ratings were released by Barrington Research, Jefferies, and Barrington Research on April 24, 2024, March 4, 2024, and February 23, 2024, respectively. With an average price target of $38 between Barrington Research, Jefferies, and Barrington Research, there's an implied 25.00% upside for Option Care Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/24/2024 | Buy Now | 25% | Barrington Research | Michael Petusky | → $38 | Maintains | Outperform | Get Alert |
03/04/2024 | Buy Now | 25% | Jefferies | Brian Tanquilut | $36 → $38 | Maintains | Buy | Get Alert |
02/23/2024 | Buy Now | 25% | Barrington Research | Michael Petusky | $35 → $38 | Maintains | Outperform | Get Alert |
10/26/2023 | Buy Now | 15.13% | Barrington Research | Michael Petusky | $41 → $35 | Maintains | Outperform | Get Alert |
10/18/2023 | Buy Now | 44.74% | JP Morgan | Lisa Gill | $46 → $44 | Maintains | Overweight | Get Alert |
07/28/2023 | Buy Now | 34.87% | Barrington Research | Michael Petusky | $34 → $41 | Maintains | Outperform | Get Alert |
06/27/2023 | Buy Now | 28.29% | Truist Securities | David Macdonald | → $39 | Reiterates | Buy → Buy | Get Alert |
05/05/2023 | Buy Now | 11.84% | Barrington Research | Michael Petusky | $38 → $34 | Maintains | Outperform | Get Alert |
05/05/2023 | Buy Now | 6.91% | Deutsche Bank | Pito Chickering | $39 → $32.5 | Maintains | Buy | Get Alert |
02/27/2023 | Buy Now | 25% | Jefferies | Brian Tanquilut | → $38 | Reinstates | → Buy | Get Alert |
10/28/2022 | Buy Now | 25% | Barrington Research | Michael Petusky | $37 → $38 | Maintains | Outperform | Get Alert |
08/22/2022 | Buy Now | 31.58% | Goldman Sachs | Jamie Perse | $31 → $40 | Maintains | Buy | Get Alert |
07/28/2022 | Buy Now | 21.71% | Barrington Research | Michael Petusky | $33 → $37 | Maintains | Outperform | Get Alert |
08/04/2021 | Buy Now | -21.05% | Canaccord Genuity | — | — | Maintains | Buy | Get Alert |
07/19/2021 | Buy Now | -17.76% | Goldman Sachs | Jamie Perse | — | Upgrade | Neutral → Buy | Get Alert |
The latest price target for Option Care Health (NASDAQ:OPCH) was reported by Barrington Research on April 24, 2024. The analyst firm set a price target for $38.00 expecting OPCH to rise to within 12 months (a possible 25.00% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Option Care Health (NASDAQ:OPCH) was provided by Barrington Research, and Option Care Health maintained their outperform rating.
The last upgrade for Option Care Health Inc happened on July 19, 2021 when Goldman Sachs raised their price target to $25. Goldman Sachs previously had a neutral for Option Care Health Inc.
There is no last downgrade for Option Care Health.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Option Care Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Option Care Health was filed on April 24, 2024 so you should expect the next rating to be made available sometime around April 24, 2025.
While ratings are subjective and will change, the latest Option Care Health (OPCH) rating was a maintained with a price target of $0.00 to $38.00. The current price Option Care Health (OPCH) is trading at is $30.40, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.